Effect of two different doses on hematological parameters in perimenopausal anemic women with heavy menstrual bleeding: A Randomized controlled trial
Phase 4
- Conditions
- Health Condition 1: null- Abnormal Uterine Bleeding
- Registration Number
- CTRI/2018/05/013854
- Lead Sponsor
- AIIMS Rishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Serum Hb >6g/dl and <10g/dl
2)Perimenopausal women in the age group of 40-51 years with anemia due to Heavy Menstrual Bleeding.
3)Not tolerating oral iron
Exclusion Criteria
1)Age less than 40 years and more than 51 years
2)Anemia due to causes other than iron deficiency anemia
3)Chronic infections like hepatitis and HIV
4)Serum transaminase level greater than 1.5 times the upper limit of normal
5)Serum creatinine level of more than 2.0mg/dl
6)Patients with history of allergic reaction to intravenous iron infusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢Rise in Hb levels / reticulocyte count above baseline, rate of rise in Hb in reference with timeTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method â?¢Proportions of people acheieving normalisation of Hb (10.9g/dL) <br/ ><br>â?¢Rise in serum ferritin and serum iron <br/ ><br>Timepoint: 3 months